Movement Disorders (revue) - Exploration (Accueil)

Index « Mesh.i » - entrée « Receptors, Dopamine D2 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Dopamine D1 < Receptors, Dopamine D2 < Receptors, Dopamine D3  Facettes :

List of bibliographic references indexed by Receptors, Dopamine D2

Number of relevant bibliographic references: 69.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000002 (2015) Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
000369 (2014) Souha Mahmoudi [Canada] ; Daniel Lévesque ; Pierre J. BlanchetUpregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
000561 (2014) Shekeeb S. Mohammad [Australie] ; Kate Sinclair ; Sekhar Pillai ; Vera Merheb ; Tim D. Aumann ; Deepak Gill ; Russell C. Dale ; Fabienne BrilotHerpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor.
000808 (2013) Bettina Balint [Allemagne] ; Kailash BhatiaReopening the case for anti-basal ganglia antibodies (ABGAs): identification of dopamine-2 receptor antibodies associated with movement disorders.
000A96 (2013) Annika Plate [Allemagne] ; Jens Benninghoff ; Gerald H. Jansen ; Elisabeth Wlasich ; Sabina Eigenbrod ; Alexander Drzezga ; Nathalie L. Jansen ; Hans A. Kretzschmar ; Kai Bötzel ; Dan Rujescu ; Adrian DanekAtypical parkinsonism due to a D202N Gerstmann-Sträussler-Scheinker prion protein mutation: first in vivo diagnosed case.
001706 (2011) Jee-Young Lee [Corée du Sud] ; Jinwhan Cho [Corée du Sud] ; Eun-Kyung Lee [Corée du Sud] ; Sung-Sup Park [Corée du Sud] ; Beom S. Jeon [Corée du Sud]Differential genetic susceptibility in diphasic and peak‐dose dyskinesias in Parkinson's disease
001719 (2011) Morvarid Karimi [États-Unis] ; Stephen M. Moerlein [États-Unis] ; Tom O. Videen [États-Unis] ; Robert R. Luedtke [États-Unis] ; Michelle Taylor [États-Unis] ; Robert H. Mach [États-Unis] ; Joel S. Perlmutter [États-Unis]Decreased striatal dopamine receptor binding in primary focal dystonia: A D2 or D3 defect?
001C97 (2010) Marta G. Vu Ckovi [États-Unis] ; Quanzheng Li [États-Unis] ; Beth Fisher [États-Unis] ; Angelo Nacca [États-Unis] ; Richard M. Leahy [États-Unis] ; John P. Walsh [États-Unis] ; Jogesh Mukherjee [États-Unis] ; Celia Williams [États-Unis] ; Michael W. Jakowec [États-Unis] ; Giselle M. Petzinger [États-Unis]Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride
002007 (2009) Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie]Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
002604 (2008) Sebastian Paus [Allemagne] ; Anne Grünewald [Allemagne] ; Christine Klein [Allemagne] ; Michael Knapp [Allemagne] ; Alexander Zimprich [Allemagne] ; Bernd Janetzky [Allemagne] ; Jens C. Möller [Allemagne] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne]The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease
002623 (2008) Yoland Smith [États-Unis] ; Rosa Villalba [États-Unis]Striatal and extrastriatal dopamine in the basal ganglia: An overview of its anatomical organization in normal and Parkinsonian brains
002763 (2008) Paolo Calabresi [Italie] ; Massimiliano Di Filippo [Italie] ; Veronica Ghiglieri [Italie] ; Barbara Picconi [Italie]Molecular mechanisms underlying levodopa‐induced dyskinesia
002999 (2008) Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Lévy [France] ; Eric Bardinet [France] ; Jérôme Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France]Apathy following subthalamic stimulation in Parkinson disease: A dopamine responsive symptom
003030 (2007) Kjell Fuxe [Suède] ; Daniel Marcellino [Suède] ; Susanna Genedani [Italie] ; Luigi Agnati [Italie]Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease
003131 (2006) Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Paola P. Piccini [Royaume-Uni]Upregulation of dopamine D2 receptors in dopaminergic drug‐naive patients with parkin gene mutations
003185 (2006) Matthias Reimold [Allemagne] ; Christoph Globas [Allemagne] ; Marc Gleichmann [Allemagne] ; Michael Schulze [Allemagne] ; Christian Gerloff [Allemagne] ; Roland Bares [Allemagne] ; H. Machulla [Allemagne] ; Katrin Bürk [Allemagne]Spinocerebellar ataxia type 1, 2, and 3 and restless legs syndrome: Striatal dopamine D2 receptor status investigated by [11C]raclopride positron emission tomography
003477 (2006) Stefanie Klaffke [Allemagne] ; Andrea A. Kuhn [Allemagne] ; Michail Plotkin [Allemagne] ; Holger Amthauer [Allemagne] ; Daniel Harnack [Allemagne] ; Roland Felix [Allemagne] ; Andreas Kupsch [Allemagne]Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration
003589 (2006) Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France]Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors
003C63 (2004) Andrew H. Evans [Royaume-Uni] ; Durval C. Costa ; Sveto Gacinovic [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Simon Heales [Royaume-Uni] ; Phillip Lee [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings
003C79 (2004) Valtteri Kaasinen [Finlande] ; Sargo Aalto [Finlande] ; Kjell N Gren [Finlande] ; Juha O. Rinne [Finlande]Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease
003D37 (2004) Ida Rissling [Allemagne] ; Frank Geller [Allemagne] ; Oliver Bandmann [Allemagne] ; Karim Stiasny-Kolster [Allemagne] ; Yvonne Körner [Allemagne] ; Charlotte Meindorfner [Allemagne] ; Hans-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; J. Carsten Möller [Allemagne]Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting “sleep attacks”

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Receptors, Dopamine D2" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Receptors, Dopamine D2" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Receptors, Dopamine D2
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024